STOCKHOLM, April 7, 2005 (PRIMEZONE) -- In accordance with the decision at the Annual General Meeting on September 21, 2004, the Chairman of the Board of Elekta AB, Mr Akbar Seddigh, today conducted a meeting with representatives for the company's largest shareholders, forming a nomination committee. The committee will develop a proposal for members of the Board to be submitted to the Annual General Meeting for decision as well as prepare other matters for the AGM.
The shareholders and their representatives who will participate in the nomination process prior to Elekta's Annual General Meeting on September 21, 2005, are:
Robur Fonder, Marianne Nilsson Egerton Capital Ltc, Charles Evans-Lombe SHB/SPP Fonder, Torsten Johansson Skandia Liv, Caroline af Ugglas SEB Fonder, Bjorn Lind Laurent Leksell (representing private and family holdings) Akbar Seddigh, Chairman of the Board of Elekta AB
As of March 31, 2005, these shareholders together represent 40 percent of the votes in Elekta AB.
The nomination committee appointed Laurent Leksell as Chairman of the committee.
Elekta is a world-leading supplier of advanced and innovative radiation oncology and neurosurgery solutions and services for precise treatment of cancer and brain disorders. Elekta's solutions are clinically effective, cost efficient and gentle to the patient.
For additional information about Elekta, please visit www.elekta.com
This information was brought to you by Waymaker http://www.waymaker.net
The following files are available for download:
http://wpy.waymaker.net/client/waymaker1/WOLReleaseFile.aspx?id=86283&fn=wkr0001.pdf